LPA-induced migration of ovarian cancer cells requires activation of ERM proteins via LPA1 and LPA2

Jeongrak Park, Jin Hyeok Jang, Seojin Oh, Minhye Kim, Changhoon Shin, Minseok Jeong, Kyun Heo, Jong Bae Park, Sang Ryong Kim, Yong Seok Oh

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

Lysophosphatidic acid (LPA) has been implicated in the pathology of human ovarian cancer. This phospholipid elicits a wide range of cancer cell responses, such as proliferation, trans-differentiation, migration, and invasion, via various G-protein-coupled LPA receptors (LPARs). Here, we explored the cellular signaling pathway via which LPA induces migration of ovarian cancer cells. LPA induced robust phosphorylation of ezrin/radixin/moesin (ERM) proteins, which are membrane-cytoskeleton linkers, in the ovarian cancer cell line OVCAR-3. Among the LPAR subtypes expressed in these cells, LPA1 and LPA2, but not LPA3, induced phosphorylation of ERM proteins at their C-termini. This phosphorylation was dependent on the Gα12/13/RhoA pathway, but not on the Gαq/Ca2+/PKC or Gαs/adenylate cyclase/PKA pathway. The activated ERM proteins mediated cytoskeletal reorganization and formation of membrane protrusions in OVCAR-3 cells. Importantly, LPA-induced migration of OVCAR-3 cells was completely abolished not only by gene silencing of LPA1 or LPA2, but also by overexpression of a dominant negative ezrin mutant (ezrin-T567A). Taken together, this study demonstrates that the LPA1/LPA2/ERM pathway mediates LPA-induced migration of ovarian cancer cells. These findings may provide a potential therapeutic target to prevent metastatic progression of ovarian cancer.

Original languageEnglish
Pages (from-to)138-147
Number of pages10
JournalCellular Signalling
Volume44
DOIs
StatePublished - Apr 2018

Keywords

  • Cell migration
  • ERM (ezrin/radixin/moesin) proteins
  • LPA receptor
  • Lysophosphatidic acid (LPA)
  • Ovarian cancer
  • RhoA

Fingerprint

Dive into the research topics of 'LPA-induced migration of ovarian cancer cells requires activation of ERM proteins via LPA1 and LPA2'. Together they form a unique fingerprint.

Cite this